Literature DB >> 23540777

Perioperative chemotherapy: when to use it, what to use, and why.

David C Johnson1, Raj S Pruthi, Michael E Woods.   

Abstract

This article provides an overview of intravesical chemotherapy agents used for non-muscle invasive bladder cancer; summarizes the evidence on single-dose perioperative administration, induction therapy, and maintenance therapy; and briefly discusses ongoing research.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23540777     DOI: 10.1016/j.ucl.2013.01.001

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  2 in total

1.  Intravesical bacillus Calmette-Guérin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer.

Authors:  Rahmi Gokhan Ekin; Ilker Akarken; Ferruh Zorlu; Huseyin Tarhan; Ulku Kucuk; Zubeyde Yildirim; Rauf Taner Divrik
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  Puerarin Inhibits Proliferation and Induces Apoptosis by Upregulation of miR-16 in Bladder Cancer Cell Line T24.

Authors:  Xiaoyun Liu; Shuguang Li; Yanyan Li; Bo Cheng; Bo Tan; Gang Wang
Journal:  Oncol Res       Date:  2018-02-08       Impact factor: 5.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.